Review
Chronopharmacology Focused on Biological Clock

https://doi.org/10.2133/dmpk.22.3Get rights and content

Summary:

The mammalians circadian pacemaker resides in the paired suprachiasmatic nuclei (SCN) and influences a multitude of biological processes, including the sleep-wake rhythm. Clock genes are the genes that control the circadian rhythms in physiology and behavior. The effectiveness and toxicity of many drugs vary depending on dosing time associated with 24 hr rhythms of biochemical, physiological and behavioral processes under the control of circadian clock. Such chronopharmacological phenomena are influenced by not only the pharmacokinetics but also pharmacodynamics of medications. Identification of a rhythmic marker for selecting dosing time will lead to improved progress and diffusion of chronopharmacotherapy. The mechanisms underlying chronopharmacological findings should be clarified from the viewpoint of clock genes. On the other hand, several drugs have an effect on circadian clock. The knowledge of interactions between circadian clock and drugs should be very useful for clinical practice. Therefore, I introduce the regulatory system of biological rhythm from viewpoints of clock genes and the possibility of pharmacotherapy based on clock genes.

References (59)

  • K. Maemura et al.

    CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression

    J. Biol. Chem.

    (2000)
  • V.G. Desai et al.

    Changes in expression level of genes as a function of time of day in the liver of rats

    Mutation Res.

    (2004)
  • F.W. Turek et al.

    Liver has rhythm

    Hepatology

    (2002)
  • F. Gachon et al.

    The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification

    Cell Metab.

    (2006)
  • B.-B.C. Youan

    Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery?

    J. Control. Rel

    (2004)
  • Z. Boulos et al.

    Food availability and daily biological rhythms

    Neurosci. Biobehav. Rev.

    (1980)
  • G. Fattovich et al.

    A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon

    J. Hepatol.

    (1996)
  • H.L.A. Janssen et al.

    Suicide associated with alfa-interferon therapy for chronic viral hepatitis

    J. Hepatol.

    (1994)
  • C.P. Lohmann et al.

    Severe loss of vision during adjuvant interferon alfa-2b treatment for malignant melanoma

    Lancet

    (1999)
  • C.A. Hunter et al.

    Type I interferons enhance production of IFN-γ by NK cells

    Immunol. Lett.

    (1997)
  • F. Halberg

    Chronobiology. Annu. Rev. Physiol.

    (1969)
  • A. Reinberg et al.

    Circadian chronopharmacology

    Annu. Rev. Pharmacol.

    (1971)
  • B. Lemmer et al.

    Chronophar-macokinetics and chronopharmacodynamics of cardiovascular active drugs: propranolol, organic nitrates, nifedipine

    Ann. N. Y. Acad. Sci.

    (1991)
  • H. Tei et al.

    Circadian oscillation of a mammalian homologue of the Drosophila period gene

    Nature

    (1997)
  • A. Kalsbeek et al.

    A diurnal rhythm of stimulatory input to the hypothalamo-pituitary-adrenal system as revealed by timed intrahypothalamic administration of the vasopressin V1 antagonist

    J. Neurosci.

    (1996)
  • J.A. Ripperger et al.

    Clock, an essential pacemaker component, controls expression of the circadian transcription factor DBP

    Genes Dev.

    (2000)
  • T. Ueyama et al.

    Suprachiasmatic nucleus: a central autonomic clock

    Nature Neurosci.

    (1999)
  • R. Silver et al.

    A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms

    Nature

    (1996)
  • A. Balsalobre et al.

    Resetting of circadian time in peripheral tissues by glucocorticoid signaling

    Science

    (2000)
  • Cited by (72)

    • Different effects of GsMTx4 on nocturia associated with the circadian clock and Piezo1 expression in mice

      2021, Life Sciences
      Citation Excerpt :

      Most drugs cause alterations in the 24-h rhythms of biochemical, physiological, and behavioral processes in complex metabolic pathways such as drug absorption, transportation, conversion, and drug-metabolizing enzyme activities [23]. These factors are affected by the circadian clock [35]. An ideal drug must be neither disruptive nor affect these processes.

    • Modified biopolymer-based chronotherapeutic drug-delivery systems

      2021, Tailor-Made and Functionalized Biopolymer Systems: For Drug Delivery and Biomedical Applications
    • The effects of P-glycoprotein inhibitor zosuquidar on the sex and time-dependent pharmacokinetics of parenterally administered talinolol in mice

      2021, European Journal of Pharmaceutical Sciences
      Citation Excerpt :

      Metabolic enzymes and drug transporters in detoxification pathways are under the control of the circadian clock, and they show circadian rhythm at gene expression and protein level (Dibner et al., 2010; Lévi et al., 2010). It is known that the pharmacokinetic profiles of many drugs may vary depending on their administration time, and circadian changes in drug transporters appear to be the major cause (Bruguerolle et al., 2008; Lévi et al., 2010; Levi and Schibler, 2007; Ohdo, 2010, 2007). The intraperitoneal (i.p.) administration route is one of the more commonly used routes in many in vivo studies of disease models in rodents (Al Shoyaib et al., 2020).

    • Optimizing the dosing schedule of L-asparaginase improves its anti-tumor activity in breast tumor-bearing mice

      2018, Journal of Pharmacological Sciences
      Citation Excerpt :

      The mean tumor volume 20 days after the start of the l-asparaginase treatment was approximately 40% smaller than that in saline-treated mice (Fig. 3C). Previous studies demonstrated that the efficacies of many drugs vary according to their administration time.10,11 Therefore, we also tested whether the anti-tumor activity of l-asparaginase was further enhanced by changing the dosing time.

    View all citing articles on Scopus
    View full text